<p>The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1 , method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.</p>
